218.80

0.03% -0.07

West Pharmaceutical Services Inc (WST)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt WST? Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$218.87

Offen:

$219.62

24-Stunden-Volumen:

646.12K

Relative Volume:

0.81

Marktkapitalisierung:

$16.36B

Einnahmen:

$2.90B

Nettoeinkommen (Verlust:

$467.20M

KGV:

34.35

EPS:

6.37

Netto-Cashflow:

$306.90M

1W Leistung:

+0.97%

1M Leistung:

+3.77%

6M Leistung:

-33.20%

1J Leistung:

-33.57%

1-Tages-Spanne:

$216.30

$221.74

1-Wochen-Bereich:

$215.66

$223.77

52-Wochen-Spanne:

$187.43

$352.33

West Pharmaceutical Services Inc Stock (WST) Company Profile

Firmenname

West Pharmaceutical Services Inc

Sektor

Healthcare (1173)

Branche

Medical Instruments & Supplies (61)

Telefon

(610) 594-2900

Adresse

530 HERMAN O. WEST DRIVE, EXTON, PA

Mitarbeiter

10,600

Twitter

@WestPharma

Nächster Verdiensttermin

2024-10-24

Neueste SEC-Einreichungen

WST's Discussions on Twitter

Vergleichen Sie WST mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
WST West Pharmaceutical Services Inc	218.80	16.36B	2.90B	467.20M	306.90M	6.37
ISRG Intuitive Surgical Inc	543.41	189.82B	8.71B	2.48B	1.75B	6.82
BDX Becton Dickinson Co	172.25	49.98B	20.87B	1.50B	2.59B	5.24
ALC Alcon Inc	88.28	44.00B	9.93B	1.12B	1.58B	2.25
RMD Resmed Inc	258.00	37.05B	5.02B	1.31B	1.56B	8.91

West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-03-18	Eingeleitet	Evercore ISI	Outperform
2025-02-14	Hochstufung	Deutsche Bank	Hold → Buy
2025-01-08	Eingeleitet	Citigroup	Buy
2024-12-13	Eingeleitet	Wolfe Research	Peer Perform
2024-12-12	Hochstufung	UBS	Neutral → Buy
2024-02-07	Hochstufung	Jefferies	Hold → Buy
2023-06-16	Hochstufung	BofA Securities	Neutral → Buy
2023-04-11	Hochstufung	Stephens	Equal-Weight → Overweight
2022-12-14	Eingeleitet	Deutsche Bank	Hold
2022-11-30	Eingeleitet	UBS	Neutral
2022-10-28	Herabstufung	BofA Securities	Buy → Neutral
2020-11-10	Eingeleitet	KeyBanc Capital Markets	Overweight
2020-10-14	Eingeleitet	Stephens	Equal-Weight
2020-07-21	Hochstufung	BofA Securities	Neutral → Buy
2020-04-24	Hochstufung	BofA/Merrill	Underperform → Neutral
2019-12-12	Herabstufung	BofA/Merrill	Neutral → Underperform
2019-07-26	Hochstufung	BofA/Merrill	Underperform → Neutral
2019-05-01	Herabstufung	Jefferies	Buy → Hold
2019-04-23	Eingeleitet	William Blair	Outperform
2018-04-25	Herabstufung	BofA/Merrill	Neutral → Underperform
2018-01-24	Eingeleitet	Goldman	Neutral
2017-10-17	Herabstufung	BofA/Merrill	Buy → Neutral
2017-10-03	Eingeleitet	Stephens	Equal-Weight
2017-09-15	Hochstufung	Jefferies	Hold → Buy
2016-10-28	Hochstufung	Wells Fargo	Market Perform → Outperform
2016-09-21	Herabstufung	Wells Fargo	Outperform → Market Perform
2016-03-22	Eingeleitet	Wells Fargo	Outperform
2010-05-14	Bestätigt	UBS	Neutral
2010-02-23	Eingeleitet	Jefferies & Co	Buy
2008-12-19	Eingeleitet	UBS	Neutral

Alle ansehen

West Pharmaceutical Services Inc Aktie (WST) Neueste Nachrichten

Jun 18, 2025

KeyBanc reiterates West Pharmaceutical stock rating on GLP-1 growth - Investing.com

Jun 18, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming DeadlinesWST - FinancialContent

Jun 18, 2025

Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline - ACCESS Newswire

Jun 18, 2025

KeyBanc reiterates West Pharmaceutical stock rating on GLP-1 growth By Investing.com - Investing.com UK

Jun 18, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services - FinancialContent

Jun 18, 2025

Jun 17, 2025

WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Jun 17, 2025

WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.

Jun 17, 2025

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services - StreetInsider

Jun 17, 2025

Securities Fraud Class Action Filed Against West Pharmaceutical Services, Inc. (WST)Levi & Korsinsky Reminds Investors of July 7, 2025 - ACCESS Newswire

Jun 17, 2025

Is West Pharmaceutical Services Stock Underperforming The Nasdaq? - Barchart.com

Jun 17, 2025

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of West Pharmaceutical Services, Inc.(WST) Shareholders - PR Newswire

Jun 17, 2025

Jun 16, 2025

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, Elevance, and West Pharmaceutical and Encourages Investors to Contact the Firm - Morningstar

Jun 16, 2025

Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire

Jun 16, 2025

2025-06-16 | Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action | NYSE:WST | Press Release - Stockhouse

Jun 16, 2025

Deadline Alert: West Pharmaceutical Services, Inc. (WST) - GlobeNewswire

Jun 16, 2025

Deadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - TradingView

Jun 16, 2025